SNP ID | Gene | Chr | Average intensity across all samples | Total number of heterozygous samples (hets) | Hets showing ASE: p < 0.01 & |lfc|>0.585 | Percentage of hets which show ASE |
---|---|---|---|---|---|---|
rs2075745 | H19 | 11 | 14.01 | 12 | 12 | 100% |
rs1860565 | PEG3 | 19 | 13.63 | 9 | 9 | 100% |
rs1802710 | DLK1 | 14 | 13.57 | 15 | 14 | 93% |
rs3730171 | GNAS | 20 | 13.54 | 1 | 0 | 0%†|
rs2839702 | H19 | 11 | 13.48 | 11 | 11 | 100% |
rs998075 | IGF2R | 6 | 12.78 | 13 | 0 | 0%* |
rs8100247 | ZNF331 | 19 | 12.61 | 13 | 12 | 92% |
rs9373409 | PLAGL1 | 6 | 12.48 | 11 | 9 | 82% |
rs13390 | PHLDA2 | 11 | 12.33 | 2 | 2 | 100% |
rs10863 | MEST | 7 | 12.32 | 4 | 4 | 100% |
rs12982082 | ZNF331 | 19 | 12.27 | 12 | 10 | 83% |
rs13073 | PEG10 | 7 | 12.09 | 11 | 10 | 91% |
rs8386 | GNAS | 20 | 11.97 | 1 | 0 | 0%†|
rs1055359 | PEG3 | 19 | 11.8 | 10 | 10 | 100% |
rs1003483 | IGF2AS | 11 | 11.32 | 8 | 7 | 88% |
rs854541 | PPP1R9A | 7 | 11.2 | 13 | 0 | 0% |
rs2285185 | L3MBTL | 20 | 10.97 | 10 | 1 | 10% |
rs2171492 | CPA4 | 7 | 10.57 | 12 | 0 | 0% |
rs2071970 | L3MBTL | 20 | 10.51 | 11 | 0 | 0% |
rs854524 | PPP1R9A | 7 | 10.41 | 10 | 0 | 0% |
rs8234 | KCNQ1 | 11 | 10.18 | 10 | 0 | 0% |
rs1049846 | PLAGL1 | 6 | 10.06 | 13 | 3 | 23% |
rs1800504 | GRB10 | 7 | 9.98 | 14 | 0 | 0% |
rs3741208 | IGF2AS | 11 | 9.67 | 10 | 0 | 0% |
rs367035 | SLC22A18 | 11 | 9.09 | 13 | 0 | 0% |
rs3816800 | ATP10A | 15 | 9.09 | 15 | 0 | 0% |
rs1570070 | IGF2R | 6 | 9.06 | 0 | 0 | 0% |
rs1800900 | GNAS | 20 | 8.86 | 9 | 2 | 22% |
rs2066710 | ATP10A | 15 | 8.8 | 16 | 0 | 0% |